MedPath

Effectiveness of Interventional package on prevention of pressure ulcers.

Not yet recruiting
Conditions
Diseases of the nervous system,
Registration Number
CTRI/2021/07/034794
Lead Sponsor
A Dipomala Devi
Brief Summary

Participants will be enrolled once ethical clearance is obtained. informed consent will be taken and baseline data will be collected followed by video-assisted teaching intervention will provide to the experimental group whereas the control group will be receiving routine care.

post-test knowledge will be tested immediately after the intervention and after the 8th week of intervention.

the experimental group will be receiving a log sheet to maintain in the home which will be assessed once in every week.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
115
Inclusion Criteria

Caregivers of adult patients with severe neurological disability with a mRS score of more than or equal to 4 irrespective of the aetiology, Patients above 18yrs of age, Willing to participate in the study.

Exclusion Criteria

Patients aged less than 18 years Caregivers who don’t know Hindi or English Patients with other uncontrolled co-morbidities Patient’s condition improves to mRS of less than or equal to 3 in period of follow up then the participants will be removed.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcomes of the trial will be a reduction in incidence of pressure ulcer from 30% to 18% (12% absolute result) with 90% CI and level of significance at 0.05.6 MONTHS
Secondary Outcome Measures
NameTimeMethod
Severity of pressure ulcers will not proceed from grade 2 to grade ≥ 3Knowledge

Trial Locations

Locations (1)

AIIMS, NEW DELHI

🇮🇳

South, DELHI, India

AIIMS, NEW DELHI
🇮🇳South, DELHI, India
A Dipomala Devi
Principal investigator
7678314311
missdipomala@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.